
Newport Pharmaceuticals Limited was established in 1995 to focus on the pharmaceutical interests of Immdal Limited, a privately owned group of companies based in Swords, Co Dublin, Ireland.
Newport's primary interest is in products for the treatment of infectious disease, immunological disorders and related conditions.
The company's current focus is on the identification of pharmaceutical drug opportunities and enhancing their value through a process of innovation and transformation.